MedTrace Logo

Effects of the Consumption of SEAweed Biomass Versus PROtein Isolates on Postprandial Satiety and Metabolism

NCT05765448 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-10-18

No results posted yet for this study

Summary

There is a need to identify alternative sources of protein that can be introduced into diets to effectively meet the protein requirements of the population. Seaweed presents a potential source of sustainable, alternative protein. In order to determine their utility in future foods, in this study we will undertake an acute postprandial trial to explore whether a macroalgae (porphyra) and a microalgae (chlorella) protein isolates are more beneficial for acute metabolic health as compared to their respective whole biomasses. In particular, we will compare the effects of whole biomasses and their protein isolates on acute glucose homeostasis, amino acid availability as well as on satiety and gut hormones.

Conditions

  • Nutrition, Healthy

Interventions

OTHER

Soy control

Soy isolate control meal

OTHER

Intervention (Laver/nori (Porphyra umbillicus) macroalgae whole biomass)

Laver/nori (Porphyra umbillicus) macroalgae whole biomass treatment meal

OTHER

Intervention (Laver/nori macroalgae (Porphyra umbillicus) protein isolates)

Laver/nori macroalgae (Porphyra umbillicus) protein isolates treatment meal

OTHER

Intervention (Chlorella microalgae (Chlorella vulgaris) whole biomass)

Chlorella microalgae (Chlorella vulgaris) whole biomass treatment meal

OTHER

Intervention (Chlorella microalgae (Chlorella vulgaris) protein isolates)

Chlorella microalgae (Chlorella vulgaris) protein isolates treatment meal

Sponsors & Collaborators

  • Singapore Institute of Food and Biotechnology Innovation

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-20
Primary Completion
2024-06-30
Completion
2024-06-30

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05765448 on ClinicalTrials.gov